Compositions, kits, and methods for isolating vesicles
US-9546938-B2 · Jan 17, 2017 · US
US10059985B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10059985-B2 |
| Application number | US-201514866386-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 25, 2015 |
| Priority date | Sep 26, 2014 |
| Publication date | Aug 28, 2018 |
| Grant date | Aug 28, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A method of amplifying a telomere of genomic DNA using an adaptor sequence, and a composition and a kit for amplifying the telomere of genomic DNA.
Opening claim text (preview).
What is claimed is: 1. A method of amplifying a telomere of genomic deoxyribonucleic acid (DNA), the method comprising: preparing a telomere fragment by incubating a sample comprising genomic DNA including a telomere with at least one nuclease, wherein the nuclease is a restriction enzyme and cleaves the genomic DNA to produce a telomere fragment having 3′-overhang; preparing a ligated telomere fragment by incubating the telomere fragment with at least one single-stranded adaptor nucleic acid and a ligase, wherein the at least one single-stranded adaptor nucleic acid comprises a first region located at the 3′ end of the single stranded adaptor nucleic acid that is complementary to a nucleic acid sequence on the 3′ overhang of the telomere fragment, thereby forming an annealed product between the telomere fragment and the single-stranded adaptor nucleic acid, and ligating the telomere fragment to the single-stranded adaptor nucleic acid in the annealed product to form the ligated telomere; preparing a blunt-end ligated telomere fragment by incubating the ligated telomere fragment with a single-strand specific exonuclease that cleaves in the 3′ to 5′ direction, a first nucleic acid polymerase, or a combination thereof; preparing a circular telomere fragment by incubating the blunt-end ligated telomere fragment with a ligase, thereby ligating the 5′ end of the one strand with the 3′ end of the same strand and the 3′ end of the other strand with the 5′ end of the same strand; and amplifying the telomere fragment by incubating the circular telomere fragment with a forward primer, a reverse primer, or a combination thereof, and a second nucleic acid polymerase, wherein the forward primer comprises a nucleic acid sequence identical to at least two contiguous nucleotides located 5′ of the first region of the single-stranded adaptor nucleic acid and the reverse primer comprises a nucleic acid sequence complementary to the at least two contiguous nucleotides located 5′ of the first region of the single-stranded adaptor nucleic acid. 2. The method of claim 1 , wherein the sample is a biological sample. 3. The method of claim 1 , wherein the single-stranded adaptor nucleic acid further comprises a second region comprising a nucleic acid sequence identical to the nucleic acid sequence of the forward primer, and a third region comprising a nucleic acid sequence complementary to the reverse primer, from a 3′-end of the adaptor nucleic acid. 4. The method of claim 1 , wherein the first region comprises a nucleic acid sequence selected from the group consisting of SEQ ID NOS: 2 to 7. 5. The method of claim 1 , wherein the exonuclease is Exonuclease I. 6. The method of claim 1 , wherein the first nucleic acid polymerase and/or the second nucleic acid polymerase is a DNA polymerase. 7. The method of claim 1 , further comprising phosphorylating a 5′-end of the ligated telomere fragment comprising a blunt end by incubating said ligated telomere fragment comprising a blunt end with a polynucleotide kinase (PNK). 8. The method of claim 1 , wherein amplifying the telomere fragment is performed by a thermal cycling amplification method or an isothermal amplification method. 9. The method of claim 1 , wherein the amplifying of the telomere fragment is performed by a polymerase chain reaction (PCR), multiple displacement amplification (MDA), nucleic acid sequence based amplification (NASBA), ligase chain reaction (LCR), strand displacement amplification (SDA), rolling circle amplification (RCA), or a combination thereof.
Ligase · CPC title
Inverse PCR · CPC title
Ligase chain reaction [LCR] · CPC title
Exonuclease · CPC title
Ligating adaptors · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.